CTRI/2018/03/012361已完成2 期
Pharmaceutico- Pharmacological study of Trivanga Bhasma and its efficacy in the management of Madhumeha (Type 2 Diabetes Mellitus)
Institute for Post Graduate Teaching and Research in Ayurved0 个研究点目标入组 89 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Both the sexes having age between 30 to 60 years.
- •2Patients having chief & associated complains of Madhumeha (Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc.)
- •3Known patient of Type 2 Diabetes Mellitus and also the preliminarily diagnosed patients based on signs and symptoms of the disease are confirmed by FBS and PPBS.
排除标准
- •1Age more than 60 and below 30 years
- •2All patients of diabetes mellitus dependent on insulin.
- •3Malignant and accelerated hypertensive.
- •4CNS disorder e.g. encephalopathy
- •5Other chronic debilitating diseases like STD etc.
- •6Pregnant woman and planning to be pregnant within six month
- •7Lactating mothers.
- •8Secondary Diabetes mellitus
- •9Diabetic nephropathy
- •10End stage renal disease
- •11Non healing Diabetic ulcer (Diabetic foot)
- •12Other chronic debilitating diseases.
研究者
相似试验
尚未招募
2 期
Efficacy of Trivanga Bhasma with Nisha Aamalaki churna in Diabetes MellitusCTRI/2024/05/067627Institute Of Teaching and Research in Ayurveda, Jamnagar
尚未招募
1 期
Role of Ayurvedic Medicine Brihatsindooradya taila inPsoriasisCTRI/2020/09/027611ATIONAL INSTITUTE OF AYURVEDA
尚未招募
2 期
Herbal toothpaste and mouthwash in the management of pyorrhoea.CTRI/2020/09/027919niversity College of Ayurveda DSRRAU Jodhpur
尚未招募
2 期
Ayuervedic Drug For Psoriasis.CTRI/2024/03/063713CCRAS
进行中（未招募）
不适用
Safety, efficacy and Pharmacokinetics of tipRanavir boosted with low-dose ritonavir TPV/r 500 mg/200 mg BID IN a racially and Gender diverse HIV-positive treatment experienced population with a pilot evaluation of therapeutic drug monitoring TDM . The SPRING study is an open-label, multicenter, multinational trial with randomisation to standard of care SOC or TDM TPV/r therapy - SPRINGRacially diverse HIV-positive population of females and males who are three-class NRTI, NNRTI, and PI experienced with a minimum of 3-months duration for each class and have documented resistance to more than one PI.MedDRA version: 9.1Level: HLTClassification code 10052740Term: Acquired immunodeficiency syndromesEUCTR2005-005264-86-ITBOEHRINGER ING.800